| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
VP, Treasurer and CFO
1 company
Alicia Grande last filed a Form 4 in December 2023, as VP, Treasurer and CFO at CPRX. Alicia Grande's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Historically, Alicia Grande's trades have earned a middling insider score of 61/100 across 10 rated trades. Over a 12-month horizon, 60.0% of those trades were profitable, with an average 12-month return of -5.5%.
Alicia Grande has 12 Form 4 filings on record from September 2022 to December 2023, all as VP, Treasurer and CFO at Catalyst Pharmaceuticals (CPRX), 2022–2023.
The 31 reported transactions were 18 open-market sales, 9 option exercises, 2 tax withholdings and 2 option or other derivative awards.
Counted by filing, the open-market trades come to no purchases and 8 sales worth about $9.5M.
The largest open-market sale was 120,000 shares of CPRX at an average $16.53 on November 22, 2022, about $2.0M. Twelve months later CPRX was down 21%.
Shares as reported in the last Form 4 for each company; the most recent is from December 2023. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 11, 2023 | CPRX Catalyst Pharmaceuticals, Inc. | VP, Treasurer and CFO | Sale+OE | 100,000 | $13.97 | $1,396,780.00 | -66.4% | +16.6% | +60.1% | |
| Mar 29, 2023 | CPRX Catalyst Pharmaceuticals, Inc. | VP, Treasurer and CFO | Sale+OE | 108,216 | $16.61 | $1,797,885.60 | -68.2% | -21.5% | -4.7% | |
| Mar 22, 2023 | CPRX Catalyst Pharmaceuticals, Inc. | VP, Treasurer and CFO | Sale+OE | 41,784 | $16.50 | $689,527.84 | -45.2% | -22.1% | +2.5% | |
| Nov 22, 2022 | CPRX Catalyst Pharmaceuticals, Inc. | VP, Treasurer and CFO | Sell | 120,000 | $16.53 | $1,983,240.00 | -81.4% | -12.9% | -20.8% | |
| Nov 15, 2022 | CPRX Catalyst Pharmaceuticals, Inc. | VP, Treasurer and CFO | Sell | 60,000 | $15.77 | $946,080.00 | -28.9% | -2.2% | -14.1% | |
| Sep 23, 2022 | CPRX Catalyst Pharmaceuticals, Inc. | VP, Treasurer and CFO | Sell | 60,000 | $11.90 | $713,940.00 | -22.4% | +63.0% | +1.9% | |
| Sep 16, 2022 | CPRX Catalyst Pharmaceuticals, Inc. | VP, Treasurer and CFO | Sell | 90,000 | $13.50 | $1,214,640.00 | -25.2% | +25.6% | -7.1% | |
| Sep 14, 2022 | CPRX Catalyst Pharmaceuticals, Inc. | VP, Treasurer and CFO | Sell | 50,000 | $15.57 | $778,650.00 | -12.3% | +14.7% | -17.5% |